Clinical Outcome of Resected Remnant Pancreatic Cancer After Resection of the Primary Pancreatic Cancer

REFERENCES

• American Cancer Society. Cancer facts and figures. 2015. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf.
   Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30. doi:10.3322/caac.21166. PMID:23335087.
   PubMed Web of Science ®Google Scholar
• Watanabe J, Otani S, Sakamoto T, Arai Y, Hanaki T, Amisaki M, et al. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today 2016;46:1258–1267. doi:10.1007/s00595-016-1308-6. PMID:26869184.
   PubMed Web of Science ®Google Scholar
• Egawa S, Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T, et al. Japan pancreatic cancer registry; 30th year anniversary japan pancreas society. Pancreas 2012;41:985–992. doi:10.1097/MPA.0b013e318258055c. PMID:22750974.
   PubMed Web of Science ®Google Scholar
• Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128:1626–1641. doi:10.1053/j.gastro.2005.03.035. PMID:15887155.
   PubMed Web of Science ®Google Scholar
• Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 1997;21:195–200 doi:10.1007/s002689900215. PMID:8995078.
   PubMed Web of Science ®Google Scholar
• Smeenk HG, Incrocci L, Kazemier G, Dekken HV, Tran KTC, Jeekel J, et al. Adjuvant 5-FUbased chemoradiotherapy for patients undergoing R-1/R-2 resections for pancreatic cancer. Dig Surg. 2005;22:321–328. doi:10.1159/000089250. PMID:16254431.
   PubMed Web of Science ®Google Scholar
• Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res. 1998;58:4740–4744. PMID:9788631.
   PubMed Web of Science ®Google Scholar
• Goggins M, Hruban RH, Kern SE. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol. 2000;156:1767–1771. doi:10.1016/S0002-9440(10)65047-X. PMID:10793087.
   PubMed Web of Science ®Google Scholar
• Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, et al. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Ann Surg. 2013;258:336–346. doi:10.1097/SLA.0b013e3182827a65. PMID:23470568.
   PubMed Web of Science ®Google Scholar
• Yachida S, White CM, Naito Y, Zhong Y, Brosnan JA, Macgregor-Das AM, et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res. 2012;18:6339–6347. doi:10.1158/1078-0432.CCR-12-1215. PMID:22991414.
   PubMed Web of Science ®Google Scholar
• Ishida J, Toyama H, Matsumoto I, Asari S, Goto T, Terai S, et al. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy. Pancreatology 2016;16:615–620. doi:10.1016/j.pan.2016.05.003. PMID:27237099.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Furukawa T, Oshima N, Izumo W, Shimizu K, Yamamoto M. Clinicopathological findings of remnant pancreatic cancers in survivors following curative resections of pancreatic cancers. World J Surg 2016;40:974–981. doi:10.1007/s00268-015-3353-5. PMID:26589594.
   PubMed Web of Science ®Google Scholar
• Wada K, Takada T, Yasuda H, Amano H, Yoshida M. A repeated pancreatectomy in the remnant pancreas 22 months after pylorus-preserving pancreatoduodenectomy for pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 2001;8:174–178. doi:10.1007/s005340170043. PMID:11455476.
   PubMedGoogle Scholar
• Eriguchi N, Aoyagi S, Imayama H, Okuda K, Hara M, Fukuda S, et al. Resectable carcinoma of the pancreatic head developing 7 years and 4 months after distal pancreatectomy for carcinoma of the pancreatic tail. J Hepatobiliary Pancreat Surg. 2000;7:316–320. Review. doi:10.1007/s005340070055. PMID:10982633.
   PubMedGoogle Scholar
• Tajima Y, Kuroki T, Ohno T, Furui J, Tsuneoka N, Adachi T, et al. Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas.Pancreas. 2008;36:324–327.
   Google Scholar
• Takamatsu S, Ban D, Irie T, Noguchi N, Kudoh A, Nakamura N, et al. Resection of a cancer developing in the remnant pancreas after a pancreaticoduodenectomy for pancreas head cancer. J Gastrointest Surg. 2005;9:263–269. doi:10.1016/j.gassur.2004.05.016. PMID:15694823.
   PubMed Web of Science ®Google Scholar
• Koizumi M, Sata N, Kasahara N, Morishima K, Sasanuma H, Sakuma Y, et al. Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: Two case reports. JOP 2010;11:36–40. PMID:20065550.
   PubMedGoogle Scholar
• Valle DR, Mancini C, Crafa P, Passalacqua R. Pancreatic carcinoma recurrence in the remnant pancreas after apancreaticoduodenectomy. JOP. 2006;7:473–477. PMID:16998244.
   PubMedGoogle Scholar
• Doi R, Ikeda H, Kobayashi H, Kogire M, Imamura M. Carcinoma in the remnant pancreas after distal pancreatectomy for carcinoma. Eur J Surg. 2002; Suppl 588:62–65.
   Google Scholar
• D'Amato A, Gentili V, Santella S, Boschetto A, Pronio A, Montesani C. Carcinoma of the pancreatic remnant developing after pancreaticoduodenectomy for adenocarcinoma of the head of pancreas. Chir Ital. 2002;54:539–544. PMID:12239765.
   PubMedGoogle Scholar
• Miura F, Takada T, Amano H, Yoshida M, Isaka T, Toyota N, et al. Repeated pancreatectomy after pancreatoduodenectomy. J Gastrointest Surg. 2007;11:179–186. doi:10.1007/s11605-006-0026-6. PMID:17390170.
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Yamade N, Nakai H, Sasaya T, Matsumura S, Kimura A, et al. Successful resection of pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy. Hepatogastroenterology 2011;58:1406–1408. doi:10.5754/hge09366. PMID:21937417.
   PubMedGoogle Scholar
• Hashimoto D, Chikamoto A, Ohmuraya M, Sakata K, Miyake K, Kuroki H, et al. Pancreatic cancer in the remnant pancreas following primary pancreatic resection. Surg Today 2014;44:1313–1320. doi:10.1007/s00595-013-0708-0. PMID:23975591.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Yoshitomi H, Shimizu H, Ohtsuka M, Yoshidome H, Furukawa K, et al. Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: Is it worthwhile. Surgery 2014;155:58–66. doi:10.1016/j.surg.2013.06.050. PMID:24238124.
   PubMed Web of Science ®Google Scholar
• Shima Y, Okabayashi T, Kozuki A, Sumiyoshi T, Tokumaru T, Saisaka Y, et al. Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature. Langenbecks Arch Surg. 2015;400:973–978. doi:10.1007/s00423-015-1355-2. PMID:26545606.
   PubMed Web of Science ®Google Scholar
• Lavu H, Nowcid LJ, Klinge MJ, Mahendraraj K, Grenda DR, Sauter PK, et al. Reoperative completion pancreatectomy for suspected malignant disease of the pancreas. J Surg Res. 2011;170:89–95. doi:10.1016/j.jss.2011.04.050. PMID:21696765.
   PubMed Web of Science ®Google Scholar
• Ogino T, Ueda J, Sato N, Takahata S, Mizumoto K, Nakamura M, et al. Repeated pancreatectomy for recurrent pancreatic carcinoma after pylorus-preserving pancreatoduodenectomy: Report of two patients. Case Rep Gastroenterol. 2010;4:429–434. doi:10.1159/000321513. PMID:21060713.
   PubMedGoogle Scholar
• Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Oxford, Wiley; 2011.
   Google Scholar
• Suzuki S, Kajiyama H, Takemura A, Shimazaki J, Nishida K, Shimoda M. The Clinical utcomes after Total Pancreatectomy. Dig Surg. 2017;34:142–150. doi:10.1159/000449234. PMID:27701159.
   PubMed Web of Science ®Google Scholar
• Müller MW, Friess H, Kleeff J, Dahmen R, Wagner M, Hinz U, et al. Is there still a role for total pancreatectomy? Ann Surg. 2007;246:966–974. doi:10.1097/SLA.0b013e31815c2ca3. PMID:18043098.
   PubMed Web of Science ®Google Scholar
• Crippa S, Tamburrino D, Partelli S, Salvia R, Germenia S, Bassi C, et al. Total pancreatectomy: Indications, different timing, and perioperative and long-term outcomes. Surgery 2011;149:79–86. doi:10.1016/j.surg.2010.04.007. PMID:20494386.
   PubMed Web of Science ®Google Scholar
• Launois B, Franci J, Bardaxoglou E, Ramee MP, Paul JL, Malledant Y, et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J Surg. 1993;17:122–127. doi:10.1007/BF01655724. PMID:8383381.
   PubMed Web of Science ®Google Scholar
• Ihse I, Lilja P, Arnesjo B, Bengmark S. Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg. 1997;186:675–680. doi:10.1097/00000658-197712000-00002.
   Google Scholar
• Tryka AF, Brooks JR. Histopathology in the evaluation of total pancreatectomy for ductal carcinoma. Ann Surg. 1979;190:373–381. doi:10.1097/00000658-197909000-00013. PMID:485612.
   PubMed Web of Science ®Google Scholar
• van Heerden JA, ReMine WH, Weiland LH, McIlrath DC, Ilstrup DM. Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. Am J Surg. 1981;142:308–311. doi:10.1016/0002-9610(81)90336-6. PMID:6269447.
   PubMed Web of Science ®Google Scholar
• SarrMG Behrns KE, van Heerden JA. Total pancreatectomy. An objective analysis of its use in pancreatic cancer. Hepatogastroenterology. 1993;40:418–421. PMID:7903658.
   PubMedGoogle Scholar
• Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979;43:1418–1428. doi:10.1002/1097-0142(197904)43:4%3c1418::AID-CNCR2820430431%3e3.0.CO;2-O. PMID:445339.
   PubMed Web of Science ®Google Scholar
• Kloppel G, Bommer G, Ruckert K, Seifert G Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch A Pathol Anat Histol 1980;387:221–233. doi:10.1007/BF00430702. PMID:7456311.
   PubMed Web of Science ®Google Scholar
• Brat DJ, Lillemoe KD, Yeo CJ, Warfield PB, Hruban RH. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol. 1998;22:163–169. doi:10.1097/00000478-199802000-00003. PMID:9500216.
   PubMed Web of Science ®Google Scholar
• Brockie E, Anand A, Albores-Saavedra J. Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol. 1998;2:286–292. doi:10.1016/S1092-9134(98)80020-8. PMID:9845751.
   PubMedGoogle Scholar
• Kleeff J, Reiser C, Hinz U, Bachmann J, Debus J, Jaeger D, et al. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg. 2007;245:566–572. doi:10.1097/01.sla.0000245845.06772.7d. PMID:17414605
   PubMed Web of Science ®Google Scholar
• Zhou Y, Song A, Wu L, Si X, Li Y. Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas: A pooled analysis. Pancreatology 2016;16;1124–1128. doi:10.1016/j.pan.2016.09.015. PMID:27717684.
   PubMed Web of Science ®Google Scholar
• Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, et al. American Cancer of the Pancreas Screening (CAPS) Consortium. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142:796–804. doi:10.1053/j.gastro.2012.01.005. PMID:22245846.
   PubMed Web of Science ®Google Scholar
• Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, et al. Dutch research group on pancreatic cancer surveillance in high-risk individuals. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut. 2016;65:1505–1513. doi:10.1136/gutjnl-2014-308008. PMID:25986944.
   PubMed Web of Science ®Google Scholar